Publications by authors named "Jennifer L Driver"

Claim this Profile
P
Preferential star strand biogenesis of pre-miR-24-2 targets PKC-alpha and suppresses cell survival in MCF-7 breast cancer cells.
Elizabeth C Martin, Steven Elliott, Lyndsay V Rhodes, James W Antoon, Claire Fewell, Jennifer L Driver

Mol Carcinog· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sphingosine kinase isoforms as a therapeutic target in endocrine therapy resistant luminal and basal-A breast cancer.
James W Antoon, Martin D White, Jennifer L Driver, Matthew E Burow, Barbara S Beckman

Exp Biol Med (Maywood)· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat.
Chandra R Tate, Lyndsay V Rhodes, H Chris Segar, Jennifer L Driver, F Nell Pounder

Breast Cancer Res· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells.
Lyndsay V Rhodes, Ashley M Nitschke, H Chris Segar, Elizabeth C Martin, Jennifer L Driver

Oncol Rep· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2.
James W Antoon, Martin D White, Evelyn M Slaughter, Jennifer L Driver, Hafez S Khalili

Cancer Biol Ther· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis